血管内碎石术治疗膝下动脉狭窄的安全性与可行性
Disrupt BTK 研究是一项前瞻性、非随机、多中心可行性与安全性试验,纳入 20 例膝下动脉中重度钙化狭窄患者,使用 Shockwave Medical 外周血管内碎石系统治疗并随访 30 天。30 天主要不良事件复合终点为 0%,靶病变直径狭窄百分比急性降低 46.5%,全部患者残余直径狭窄≤50%。
要点
- 20 例膝下动脉钙化狭窄患者接受血管内碎石术,19 例导管输送成功。
- 30 天主要不良事件复合终点为 0%,无器械相关并发症。
- 靶病变直径狭窄百分比急性降低 46.5%,全部患者残余狭窄≤50%。
核心结论
- 这项先导研究的早期结果显示,钙化性膝下动脉狭窄可安全且成功地采用血管内碎石术治疗。
研究设计与样本
- Disrupt BTK 研究为前瞻性、非随机、多中心可行性与安全性试验,在 3 个参与中心纳入 20 例患者(平均年龄 79.0±9.6 岁;14 例男性),ClinicalTrials.gov 标识 NCT02911623。
- 15 例患者为 Rutherford 5 级缺血,全部患者存在膝下动脉中重度钙化。
- 患者接受 Shockwave Medical 外周血管内碎石系统治疗并随访 30 天。
主要发现
- 血管内碎石导管输送在 19 例患者中成功。
- 30 天主要不良事件复合终点为 0%。
- 靶病变直径狭窄百分比急性降低 46.5%。
- 全部患者达到残余直径狭窄≤50%。
- 血管并发症轻微,仅报告 1 例 B 型夹层并置入 2 枚支架;无患者发生血栓形成、血管突然闭塞、远端栓塞或穿孔;无器械相关并发症。
关键数值与推荐
- 主要安全终点为 30 天内主要不良事件复合终点,定义为死亡、心肌梗死、靶肢体需紧急外科血运重建或靶肢体截肢。
- 主要有效性结局为直径狭窄百分比的急性降低。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the safety and feasibility of treating calcified infrapopliteal stenoses using an intravascular lithotripsy (IVL) system. METHODS: The Disrupt BTK study was a prospective, nonrandomized, multicenter, feasibility, and safety trial that enrolled 20 patients (mean age 79.0±9.6 years; 14 men) at 3 participating sites ( ClinicalTrials.gov identifier NCT02911623). Fifteen patients had Rutherford category 5 ischemia, and all patients had moderate to severe below-the-knee arterial calcification. Patients were treated with the Shockwave Medical Peripheral IVL System and followed for 30 days. The primary safety endpoint was a composite of major adverse events through 30 days defined as death, myocardial infarction, need for emergency surgical revascularization of the target limb, or amputation of the target limb. The primary effectiveness outcome was acute reduction in the percent diameter stenosis. RESULTS: IVL catheter delivery was successful in 19 patients. The composite of major adverse events at 30 days was 0%. The acute reduction in percent diameter stenosis of target lesions was 46.5%. All patients achieved residual diameter stenosis ≤50%. Vascular complications were minimal with only 1 type B dissection reported and 2 stents placed. None of the subjects experienced thrombus formation, abrupt closure, distal embolization, or perforation. There were no device-related complications. CONCLUSION: The early results of this pilot study demonstrated that calcified, stenotic infrapopliteal arteries can be safely and successfully treated with intravascular lithotripsy.
引用
- Brodmann M, Holden A, Zeller T, et al. Safety and Feasibility of Intravascular Lithotripsy for Treatment of Below-the-Knee Arterial Stenoses. J Endovasc Ther. 2018. PMID: 29911480. doi:10.1177/1526602818783989
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。